Clinical Trial Update: LiveSMART Trial to Prevent Falls in Patients With Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 LiveSMART trial evaluating falls prevention in patients with cirrhosis has completed. The study enrolled patients with cirrhosis and portal hypertension…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis of the Liver
• Portal Hypertension

Snippet

Sponsor: University of Michigan | Conditions: Cirrhosis, Liver, Portal Hypertension | Phase 3 | Status: COMPLETED